Modified capitation and treatment incentives for end stage renal disease.

Autor: Farley DO; Physician Payment Review Commission, Washington, DC 20037, USA., Carter GM, Kallich JD, Lucas TW, Spritzer KL
Jazyk: angličtina
Zdroj: Health care financing review [Health Care Financ Rev] 1996 Spring; Vol. 17 (3), pp. 129-42.
Abstrakt: This study developed a modified capitation payment method for the Medicare end stage renal disease (ESRD) program designed to support appropriate treatment choices and protect health plans from undue financial risk. The payment method consists of risk-adjusted monthly capitated payments for individuals on dialysis or with functioning kidney grafts, lump sum event payments for expected incremental costs of kidney transplantations or graft failures, and outlier payments for expensive patients. The methodology explained 25 percent of variation in annual payments per patient. Risk adjustment captured substantial variations across patient groups. Outlier payments reduced health plan risk by up to 15 percent.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje